AI accelerates drug discovery, new therapy for fatal pulmonary fibrosis emerges

The article highlights AI's role in accelerating drug discovery, specifically a new therapy for pulmonary fibrosis. It contrasts the hype around AI risks with its tangible benefits in medical research. The claim is based on reported progress, but specific trial data or regulatory status is not detailed.